Gauthé M - Search Results

1

A Hungry Bone Syndrome Predicted by 18F-Fluorocholine PET/CT.

Paepegaey AC, Velayoudom FL, Housni S, Gauthé M, Groussin L. Paepegaey AC, et al. Among authors: gauthe m. Clin Nucl Med. 2019 Nov;44(11):903-904. doi: 10.1097/RLU.0000000000002676. Clin Nucl Med. 2019. PMID: 31274564

2

French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Management of metastatic disease and castration resistance.

Ploussard G, Roubaud G, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Renard-Penna R, Rozet F, Ruffion A, Sargos P, Mathieu R, Rouprêt M; Comité de Cancérologie de l’Association française d’Urologie, groupe prostate. Ploussard G, et al. Among authors: gauthe m. Prog Urol. 2022 Nov;32(15):1373-1419. doi: 10.1016/j.purol.2022.07.147. Prog Urol. 2022. PMID: 36400484 Review.

3

Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT.

Gauthé M, Lièvre A, Alberini JL. Gauthé M, et al. Clin Nucl Med. 2015 Nov;40(11):e516-7. doi: 10.1097/RLU.0000000000000911. Clin Nucl Med. 2015. PMID: 26204216

4

18F-Fluorocholine PET/CT of Incidental Male Breast Cancer.

Hugentobler A, Gilbeau L, Talbot JN, Gauthé M. Hugentobler A, et al. Among authors: gauthe m. Clin Nucl Med. 2017 Jan;42(1):e56-e57. doi: 10.1097/RLU.0000000000001429. Clin Nucl Med. 2017. PMID: 27775938

5

Uterine leiomyosarcoma metastatic to thyroid shown by ¹⁸F-FDG PET/CT imaging.

Gauthé M, Testart Dardel N, Nascimento C, Trassard M, Banal A, Alberini JL. Gauthé M, et al. Rev Esp Med Nucl Imagen Mol. 2017 Mar-Apr;36(2):113-115. doi: 10.1016/j.remn.2016.09.002. Epub 2016 Oct 21. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 27777040 English, Spanish.

6

Pituitary Adenoma Recurrence Suspected on Central Hyperthyroidism Despite Empty Sella and Confirmed by 68Ga-DOTA-TOC PET/CT.

Gauthé M, Sarfati J, Bourcigaux N, Christin-Maitre S, Talbot JN, Montravers F. Gauthé M, et al. Clin Nucl Med. 2017 Jun;42(6):454-455. doi: 10.1097/RLU.0000000000001628. Clin Nucl Med. 2017. PMID: 28263215

7

[PET/CT and biochemical recurrence of prostate adenocarcinoma: Added value of ⁶⁸Ga-PSMA-11 when ¹⁸F-fluorocholine is non-contributive].

Gauthé M, Belissant O, Girard A, Zhang Yin J, Ohnona J, Cottereau AS, Nataf V, Balogova S, Pontvert D, Lebret T, Guillonneau B, Cussenot O, Talbot JN. Gauthé M, et al. Prog Urol. 2017 Jun-Jul;27(8-9):474-481. doi: 10.1016/j.purol.2017.04.004. Epub 2017 May 30. Prog Urol. 2017. PMID: 28576423 French.

8

Diagnostic performance and impact on patient management of ⁶⁸Ga-DOTA-TOC PET/CT for detecting osteomalacia-associated tumours.

Paquet M, Gauthé M, Zhang Yin J, Nataf V, Bélissant O, Orcel P, Roux C, Talbot JN, Montravers F. Paquet M, et al. Among authors: gauthe m. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1710-1720. doi: 10.1007/s00259-018-3971-x. Epub 2018 Mar 12. Eur J Nucl Med Mol Imaging. 2018. PMID: 29532101

9

False-Positive Results in 18F-Fluorocholine PET/CT for a Thymoma in Workup of a Hereditary Primary Hyperparathyroidism.

Bricaire L, Richard C, Gauthé M, Cochand-Priollet B, Gaujoux S. Bricaire L, et al. Among authors: gauthe m. Clin Nucl Med. 2018 May;43(5):e151-e153. doi: 10.1097/RLU.0000000000002034. Clin Nucl Med. 2018. PMID: 29538025

10

Visualization of Macroprolactinoma by ¹⁸F-Fluorocholine PET/CT in a Patient With Multiple Endocrine Neoplasia Type 1.

Paepegaey AC, Gaujoux S, Cottereau AS, Groussin L, Gauthe M. Paepegaey AC, et al. Among authors: gauthe m. J Endocr Soc. 2018 Sep 13;2(10):1170-1172. doi: 10.1210/js.2018-00193. eCollection 2018 Oct 1. J Endocr Soc. 2018. PMID: 30302421 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page